Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core segment. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia in 1989 and is headquartered in Carlsbad, CA.

Qingdao Jiarui Biotechnology Co., Ltd., established on 2013-10-25, Business scope includes general business items:Biological Product Technology Development,technology transfer,technical consulting,Technical Services,Health food development,technology transfer,technical consulting,Technical Services,Enterprise Marketing Planning. (The above scope needs to be licensed to operate,Operate with a license).

The Eli and Edythe L. Broad Institute of MIT and Harvard (/ˈbroʊd/), often referred to as the Broad Institute, is a biomedical and genomic research center located in Cambridge, Massachusetts, United States. The institute is independently governed and supported as a 501(c)(3) nonprofit research organization under the name Broad Institute Inc., and is partners with Massachusetts Institute of Technology, Harvard University, and the five Harvard teaching hospitals.

PLTTECH engages in the R&D of single-cell precision research solutions. It is based on single-cell research in the field of precision medicine, and applies technological research and innovation to disease research and health management. The company aggregates the world's leading technologies such as single-cell detection, protein dynamic detection, and biological big data analysis, and provides excellent solutions for precision medicine and health management through extensive cooperation in the fields of medical scientific research, clinical diagnosis and treatment, and drug research and development. The company was founded in 2015 and is based in Hangzhou, China.

Seattle-based biotechnology company focused on targeting cancer to transform lives through the discovery, development and commercialization of novel therapeutics to fight cancer. Dendreon applies its expertise in antigen identification, engineering and cell processing to produce Active Cellular Immunotherapy (ACI) product candidates designed to stimulate an immune response. ACI holds promise because it may provide patients with a meaningful clinical benefit, such as survival, combined with low toxicity. In addition to ACI product candidates, the company is also developing an orally-available small molecule targeting TRPM8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia.

Puxi (Guangzhou) Bioimmune Technology Co., Ltd., established on 2017-06-21, Business scope includes medical research and experimental development;R&D and application of cell technology;Health Consulting Services(Does not include medical services);Non-residential real estate leases;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Information Technology Consulting Services;Remote Health Management Services;R&D and application of cell technology;Human stem cell technology development and application;Sales of hygiene products and single-use medical products;Medical equipment rental;Inspection and testing service;Internet Information Service for Medical Devices;Class III medical device business

Beijing Dabeinong Technology Group Co., Ltd. engages in the manufacture, process, and sale of feed and seed products. It also deals with the import and export of animal health and plant protection products. The company was founded by Gen Huo Shao on December 28, 1993 and is headquartered in Beijing, China.

EUROIMMUN AG develops and manufactures medical laboratory reagents for the diagnosis of autoimmune and infectious diseases and allergies. It offers indications for autoimmunity, infections, allergology, antigen detection, and molecular diagnostics; autoimmunity products for rheumatology, hepatology, gastroenterology, endocrinology, neurology, nephrology, dermatology, and infertility; and infection products for immunity determination, CSF diagnostics, emerging viruses, avidity, BIOCHIP Mosaics for infectious serology, and others, as well as additional reagents for determination of acute infections.

Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.

Universal Medicine is a technology developer in the field of immune system, dedicated to the development of key technologies for high-throughput reading and writing of T and B lymphocyte receptor profiles and their applications in clinical testing and treatment, focusing on technology developers in the field of immune system . Recently announced the completion of a 30 million RMB Pre-A round of strategic financing. WinX Capital is acting as a financial advisor. This round of investment was initiated by Kangsheng Global. Ruijiang Kangsheng Fund managed by Ruijiang Investment led the investment. The investors included Spark Venture Capital and Yangtze River Source Fund. This round of funds will be mainly used for the promotion of hematological tumor MRD products and the research and development of new clinical products.

Part of Southern Medical University, Zhujiang Hospital of Southern Medical University is a company headquartered in Guangzhou, China, that operates hospital.

Maruho Co., Ltd. engages in the research, development, manufacture, and marketing of pharmaceutical products. It specializes in the production of dermatology and topical drugs. Its products include Hirudoid Cream, Eksalb, Rozex Gel, Casal Cream, Farom Tablets, and Telgin G Dry Syrup. The company was founded by Eikuma Koba in July 1915 and is headquartered in Osaka, Japan.

Kemei Boyang Diagnostic Technology (Shanghai) Co., Ltd., established on 2005-08-17, Business scope includes general items:Diagnostic Technology,medical technology,Biological Technology(human stem cells,Except for the development and application of genetic diagnosis and treatment technology)technical services in the field,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Biological product,Chemical products and raw materials(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals)research and development;Specialty Chemicals Sales(Free of Hazardous Chemicals);Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Own Equipment Rental;Import and export;Technology Import and Export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license) licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Guangzhou Raide Medical Laboratory Co., Ltd., established on 2017-07-12, The scope of business includes clinical laboratory services;Genetic testing and disease screening services;collection of stem cells,storage,preparation service(Without umbilical cord blood hematopoietic stem cell collection,storage);Collection of immune cells,storage,preparation service(Without umbilical cord blood hematopoietic stem cell collection,storage);Technology development of stem cell engineering series products;Research and development of stem cell series technical engineering products;Stem Cell Biotechnology Consulting Services;Stem Cell Biotechnology Transfer Services;Stem Cell Biotechnology Services;Natural science research and experimental development;Human Science Research,to develop;Health Sciences Program Research,to develop;Stem Cell Technology Research,to develop;Medical Research and Experimental Development;Biomedical Technology Research;Regenerative Medicine Anti-aging Research Services;Medical technology research and development;drug development;Gene drug development;Stem Cell Drug Development;Pharmaceutical Research Services;Biotechnology Extension Services;Biotechnology Development Services;Biotechnology Consulting,communication service;Biotechnology Transfer Services;Human Science Research Achievement Transfer Service;Medical technology promotion service;Medical Technology Consulting,communication service;Medical technology transfer service;Technology intermediary service;Science and Technology Information Consulting Services;Technology project agency service;Technology project bidding service;Science and technology project evaluation service;Scientific and technological achievements appraisal service;Research and development and technology transfer of health science;Health Sciences Program Research Transfer;Technology Promotion of Research Results of Health Science Projects;Life Engineering Project Development;

Biotogether Co. Ltd. develops pharmaceutical intermediates , food additives, animal feed additives, and raw materials used in cosmetics and nutraceuticals. The company was founded in 2005 and is headquartered in Nanjing, China.